T1	Participants 67 121	before endoscopic retrograde cholangiopancreatography.
T2	Participants 209 263	endoscopic retrograde cholangiopancreatography (ERCP).
T3	Participants 479 495	studied subjects
T4	Participants 535 600	1 mg glucagon (n = 38) or 40 mg hyoscine N-butyl bromide (n = 36)
